Article Details
Retrieved on: 2024-07-11 18:19:32
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses current advancements in atherosclerosis treatment and closely ties to the key concept of 'Epidemiology' by providing detailed insights into clinical trials, emerging therapies, and the involvement of pharmaceutical companies like Merck & Co. and Amgen in developing treatments for vascular diseases like atherosclerosis. Tags such as 'Vascular diseases', 'Apolipoproteins', 'Cardiology', and 'Lipoprotein' reflect the article's focus areas and relevance to the epidemiological study of these conditions.
Article found on: www.openpr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here